Literature DB >> 21031373

Interaction of the human prion protein PrP106-126 with metal complexes: potential therapeutic agents against prion disease.

Yanli Wang1, Jia Xu, Lu Wang, Bingbing Zhang, Weihong Du.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21031373     DOI： 10.1002/chem.201002207

Source DB:  PubMed          Journal:  Chemistry        ISSN： 0947-6539            Impact factor:   5.236


× No keyword cloud information.
  4 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes.

Authors:  Weihong Du; Gehui Gong; Wenji Wang; Jufei Xu
Journal:  J Biol Inorg Chem       Date:  2017-08-11       Impact factor: 3.358

3.  Gold complexes inhibit the aggregation of prion neuropeptides.

Authors:  Xuesong Wang; Lei He; Cong Zhao; Weihong Du; Jun Lin
Journal:  J Biol Inorg Chem       Date:  2013-08-28       Impact factor: 3.358

4.  Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands.

Authors:  Daniele Florio; Ilaria Iacobucci; Giarita Ferraro; Ahmed M Mansour; Giancarlo Morelli; Maria Monti; Antonello Merlino; Daniela Marasco
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.